<DOC>
	<DOCNO>NCT00003996</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one chemotherapy drug radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy plus radiation therapy treat patient newly diagnose glioblastoma multiforme .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Newly Diagnosed Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate efficacy carmustine , cisplatin , etoposide administer prior radiotherapy patient newly diagnose high grade glioblastoma multiforme . II . Assess toxicity treatment regimen patient population . III . Assess fatigue , depression , excessive daytime somnolence term incidence , duration , relation age , tumor type , tumor site , cancer therapy , symptoms patient population . IV . Evaluate quality life patient . OUTLINE : Patients receive pre-irradiation chemotherapy consist carmustine IV 1 hour day 1-3 oral etoposide day 1-21 29-49 immediately follow cisplatin IV 1-2 hour day 1-3 29-31 . Treatment repeat every 8 week 2 course . Patients receive concurrent cranial radiotherapy daily 8 week course 2 . Patients receive carmustine IV 1-2 hour every 8 week 4 course . Treatment continue absence disease progression unacceptable toxicity . Quality life assess study , prior treatment course , every 4 month 1 year , every 6 month 4 year , annually 5 year . Patients follow every 4 month 1 year , every 6 month 4 year , annually 5 year , survival .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm newly diagnose glioblastoma multiforme No oligodendrogliomas oligoastrocytomas PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,500/mm3 Platelet count least 130,000/mm3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT great 2 time ULN Renal : Creatinine great 0.5 mg/dL ULN Other : No uncontrolled infection No major medical condition No concurrent malignancy except superficial skin cancer Must able read English ( quality life assessment ) No problem may preclude quality life assessment Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Concurrent steroid allow Radiotherapy : No prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>